GlassScriptPhysician profile
Jerry W Robinson
NPI 1841251691
$869.29
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.14 · 2020: $70.62 · 2021: $33.94 · 2022: $239 · 2023: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $147.62 | 2020-2023 | Wegovy |
| Abbvie INC. | $128.18 | 2020-2023 | Vraylar, Dalvance, Qulipta |
| Lilly USA, LLC | $108.80 | 2022-2023 | Mounjaro, Jardiance, Lyumjev |
| Novartis Pharmaceuticals Corporation | $63.63 | 2022-2023 | |
| Amgen INC. | $53.18 | 2019 | |
| Exact Sciences Corporation | $45.43 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $44.25 | 2019-2023 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $43.60 | 2020-2023 | Breztri |
| Glaxosmithkline, LLC. | $39.06 | 2020-2023 | Arexvy, Shingrix |
| Dexcom, INC. | $35.22 | 2023 | Dexcom G6 Transmitter |
| Allergan, INC. | $32.22 | 2020-2022 | |
| Antares Pharma, INC. | $29.83 | 2023 | Nocdurna, Xyosted, Tlando |
| Pfizer INC. | $28.29 | 2019-2023 | |
| Boston Scientific Corporation | $16.53 | 2019 | |
| Scilex Pharmaceuticals INC. | $16.09 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $13.21 | 2023 | |
| Insmed, INC. | $12.97 | 2022 | |
| Eisai INC. | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.